Bethel, M A; Deedwania, P; Levitt, N S; Schmitz, O; Huntsman-Labed, A; Califf, R M; Haffner, S M; Diem, P (2009). Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. Diabetic medicine, 26(12), pp. 1204-11. Chichester: Wiley 10.1111/j.1464-5491.2009.02864.x
Full text not available from this repository. (Request a copy)Non-alcoholic fatty liver disease (NAFLD) is associated with features of the metabolic syndrome (MetS) and may be an expression of the syndrome within the liver. Using screening data from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) study (n = 42 149), we examined whether alanine aminotransferase (ALT), a biomarker for NAFLD, clustered with features of MetS and whether the clusters differed across global geographic regions.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition |
UniBE Contributor: |
Diem, Peter |
ISSN: |
0742-3071 |
Publisher: |
Wiley |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:14 |
Last Modified: |
05 Dec 2022 14:22 |
Publisher DOI: |
10.1111/j.1464-5491.2009.02864.x |
PubMed ID: |
20002471 |
Web of Science ID: |
000272161900004 |
URI: |
https://boris.unibe.ch/id/eprint/32470 (FactScience: 197679) |
Actions (login required)
 |
Edit item |